J&J Bows Out of Race for Pfizer's $20B Consumer Health Biz Post author:Sam Post published:January 25, 2018 Post category:BioPharma Now insiders say J&J has decided it is no longer interested. Source: BioSpace You Might Also Like What You Need to Know About DMD Therapeutics January 29, 2018 Boy Wonder Roivant Bets $116 Million on Arbutus October 1, 2017 Many Employees Moved to Boston as Part of Takeda's Transformation September 4, 2017
